Private Capital Group, LLC Uni Qure N.V. Transaction History

Private Capital Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$14.54 - $21.5 $5,161 - $7,632	-355 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$20.24 - $36.01 $2,914 - $5,185	144 Added 68.25%	355 $7,000
Q3 2021 Oct 13, 2021	SELL	$26.01 - $38.22 $3,225 - $4,739	-124 Reduced 37.01%	211 $7,000
Q2 2021 Jul 26, 2021	SELL	$29.97 - $37.17 $5,964 - $7,396	-199 Reduced 37.27%	335 $10,000
Q1 2021 Apr 12, 2021	SELL	$29.24 - $42.03 $3,040 - $4,371	-104 Reduced 16.3%	534 $18,000
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $22,955 - $30,407	638 New	638 $23,000

141

33.7M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $230M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.